LRMR Return on Tangible Equity | LARIMAR THERAPEUTICS, INC.

LARIMAR THERAPEUTICS, INC. (LRMR) Return on Tangible Equity

2026-06-30: Return Tang Equity -135.50%.
2026-03-31: Return Tang Equity -105.04%.
2025-12-31: Return Tang Equity -212.17%.
2025-09-30: Return Tang Equity -94.94%.

Complete source-backed return tang equity history.

Available history: 2012-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-135.50%
2026-03-31	-105.04%
2025-12-31	-212.17%
2025-09-30	-94.94%
2025-06-30	-83.26%
2025-03-31	-66.01%
2024-12-31	-46.91%
2024-09-30	-32.65%
2024-06-30	-27.60%
2024-03-31	-19.53%
2023-12-31	-45.21%
2023-09-30	-36.01%
2023-06-30	-32.66%
2023-03-31	-31.00%
2022-12-31	-31.88%
2022-09-30	-29.55%
2022-06-30	-87.00%
2022-03-31	-83.16%
2021-12-31	-78.61%
2021-09-30	-77.30%
2021-06-30	-72.82%
2021-03-31	-60.79%
2020-12-31	-47.36%
2020-09-30	-33.47%
2020-06-30	-29.06%
2020-03-31	-1111.79%
2019-12-31	3333.14%
2019-09-30	-1667.16%
2019-06-30	-7010.13%
2019-03-31	-4096.08%
2018-12-31	-2105.97%
2018-09-30	-57.61%
2018-06-30	-110.34%
2018-03-31	-84.58%
2017-12-31	-66.52%
2017-09-30	-55.34%
2017-06-30	-51.67%
2017-03-31	-47.98%
2016-12-31	-47.55%
2016-09-30	-54.25%
2016-06-30	-53.31%
2016-03-31	-50.87%
2015-12-31	-43.93%
2015-09-30	-32.71%
2015-06-30	-27.57%
2015-03-31	-20.52%
2014-12-31	-34.93%
2014-09-30	-26.43%
2014-06-30	-14.52%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-212.17%
2024-12-31	-46.91%
2023-12-31	-45.21%
2022-12-31	-31.88%
2021-12-31	-78.61%
2020-12-31	-47.36%
2019-12-31	3333.14%
2018-12-31	-2105.97%
2017-12-31	-66.52%
2016-12-31	-47.55%
2015-12-31	-43.93%
2014-12-31	-34.93%
2013-12-31	20.46%
2012-12-31	25.36%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Emergent BioSolutions Inc. (EBS)	United States	$0.347B	-2.43
ENANTA PHARMACEUTICALS INC (ENTA)	United States	$0.349B	-6.72
Benitec Biopharma Inc. (BNTC)	United States	$0.337B	-10.08
BioAge Labs, Inc. (BIOA)	United States	$0.333B	-11.88
Vogenx, Inc. (VOGX)	United States	$0.355B
BridgeBio Oncology Therapeutics, Inc. (BBOT)	United States	$0.320B	-3.35
Evommune, Inc. (EVMN)	United States	$0.320B	-5.10
Prelude Therapeutics Inc (PRLD)	United States	$0.318B	-7.01
ABEONA THERAPEUTICS INC. (ABEO)	United States	$0.312B	-5.63
GT Biopharma, Inc. (GTBP)	United States	$0.309B	-4.58